Otoferlin
| OTOF | |||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Identifiers | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Aliases | OTOF, AUNB1, DFNB6, DFNB9, FER1L2, NSRD9, otoferlin | ||||||||||||||||||||||||||||||||||||||||||||||||||
| External IDs | OMIM: 603681; MGI: 1891247; HomoloGene: 12892; GeneCards: OTOF; OMA:OTOF - orthologs | ||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| Wikidata | |||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Otoferlin is a protein that in humans is encoded by the OTOF gene.[5][6][7]
Function
[edit]There are two forms of otoferlin protein. The short form of the protein has three C2 domains and a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin. The long form has six C2 domains.
Dysferlin and myoferlin are proteins found in humans that are homologous to otoferlin. Both dysferlin and myoferlin have seven C2 domains. A C2 domain is a protein structural domain involved in targeting proteins to cell membranes.
C2A in otoferlin's longer form, with six C2 domains, is structurally similar to dysferlin C2A. However, loop 1 in the calcium (Ca2+) binding site of otoferlin C2A is significantly shorter than the homologous loop in dysferlin and myoferlin C2A domains. Therefore, it is unable to bind to calcium. Otoferlin C2A is also unable to bind to phospholipids and hence it is structurally and functionally distinct from other C2 domains.[8] Nonetheless, the homology suggests that this protein may be involved in vesicle membrane fusion.
Similar to dysferlin and myoferlin, otoferlin has a FerA domain and its FerA domain has been shown to interact with zwitterionic lipids in a calcium-dependent manner and with negatively charged lipids in a calcium-independent manner.[9] The estimated charge of the FerA domain among ferlin proteins varies significantly. At pH 7, the estimated charge of dysferlin is -8.4 while otoferlin FerA is +8.5.[9] Several transcript variants encoding multiple isoforms have been found for this gene.[7]
Clinical significance
[edit]Mutations in the gene encoding otoferlin are the cause of nonsyndromic recessive deafness type 9.
Gene therapies for restoring the defective Otoferlin using an adeno-associated virus (AAVs) have been under development for some time,[10][11] including AAVAnc80-hOTOF used in experimental gene therapy in humans.[12][13] A successful application of the therapy in Britain was announced in May 2024.[14][15] Lunsotogene parvec-cwha is a therapy approved for use in the United States.
References
[edit]- 1 2 3 GRCh38: Ensembl release 89: ENSG00000115155 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000062372 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Yasunaga S, Grati M, Cohen-Salmon M, El-Amraoui A, Mustapha M, Salem N, et al. (April 1999). "A mutation in OTOF, encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness". Nature Genetics. 21 (4): 363–369. doi:10.1038/7693. PMID 10192385. S2CID 19269361.
- ↑ Rodríguez-Ballesteros M, Reynoso R, Olarte M, Villamar M, Morera C, Santarelli R, et al. (June 2008). "A multicenter study on the prevalence and spectrum of mutations in the otoferlin gene (OTOF) in subjects with nonsyndromic hearing impairment and auditory neuropathy". Human Mutation. 29 (6): 823–831. doi:10.1002/humu.20708. PMID 18381613. S2CID 19170712.
- 1 2 "Entrez Gene: OTOF otoferlin".
- ↑ Helfmann S, Neumann P, Tittmann K, Moser T, Ficner R, Reisinger E (February 2011). "The crystal structure of the C₂A domain of otoferlin reveals an unconventional top loop region". Journal of Molecular Biology. 406 (3): 479–490. doi:10.1016/j.jmb.2010.12.031. PMID 21216247.
- 1 2 Harsini FM, Chebrolu S, Fuson KL, White MA, Rice AM, Sutton RB (July 2018). "FerA is a Membrane-Associating Four-Helix Bundle Domain in the Ferlin Family of Membrane-Fusion Proteins". Scientific Reports. 8 (1) 10949. Bibcode:2018NatSR...810949H. doi:10.1038/s41598-018-29184-1. PMC 6053371. PMID 30026467.
- ↑ Jiang L, Wang D, He Y, Shu Y (April 2023). "Advances in gene therapy hold promise for treating hereditary hearing loss". Molecular Therapy (Review). 31 (4): 934–950. doi:10.1016/j.ymthe.2023.02.001. PMC 10124073. PMID 36755494.
- ↑ Hickox AE, Valero MD, McLaughlin JT, Robinson GS, Wellman JA, McKenna MJ, et al. (November 2021). "Genetic Medicine for Hearing Loss: OTOF as Exemplar". Journal of the American Academy of Audiology (Review). 32 (10): 646–653. doi:10.1055/s-0041-1730410. PMID 35609591.
- ↑ Regalado A (2023-10-27). "Some deaf children in China can hear after gene therapy treatment". MIT Technology Review. Retrieved 2023-11-09.
- ↑ "Regeneron Shares Preliminary Results Showing GENE Therapy Improves Auditory Responses in Child WITH Profound Genetic Hearing LOSS". Regeneron Pharmaceuticals. 26 October 2023.
- ↑ Roberts M (2024-05-08). "Pioneering gene therapy restores UK girl's hearing". BBC News. Retrieved 2024-05-09.
- ↑ Gregory A (2024-05-09). "UK toddler has hearing restored in world-first gene therapy trial". The Guardian. Retrieved 2024-05-09.
External links
[edit]Further reading
[edit]- Fukushima K, Ramesh A, Srisailapathy CR, Ni L, Wayne S, O'Neill ME, et al. (October 1995). "An autosomal recessive nonsyndromic form of sensorineural hearing loss maps to 3p-DFNB6". Genome Research. 5 (3): 305–308. doi:10.1101/gr.5.3.305. PMID 8593615.
- Yasunaga S, Petit C (May 2000). "Physical map of the region surrounding the OTOFERLIN locus on chromosome 2p22-p23". Genomics. 66 (1): 110–112. doi:10.1006/geno.2000.6185. PMID 10843812.
- Adato A, Raskin L, Petit C, Bonne-Tamir B (June 2000). "Deafness heterogeneity in a Druze isolate from the Middle East: novel OTOF and PDS mutations, low prevalence of GJB2 35delG mutation and indication for a new DFNB locus". European Journal of Human Genetics. 8 (6): 437–442. doi:10.1038/sj.ejhg.5200489. PMID 10878664.
- Yasunaga S, Grati M, Chardenoux S, Smith TN, Friedman TB, Lalwani AK, et al. (September 2000). "OTOF encodes multiple long and short isoforms: genetic evidence that the long ones underlie recessive deafness DFNB9". American Journal of Human Genetics. 67 (3): 591–600. doi:10.1086/303049. PMC 1287519. PMID 10903124.
- Migliosi V, Modamio-Høybjør S, Moreno-Pelayo MA, Rodríguez-Ballesteros M, Villamar M, Tellería D, et al. (July 2002). "Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing loss". Journal of Medical Genetics. 39 (7): 502–506. doi:10.1136/jmg.39.7.502. PMC 1735186. PMID 12114484.
- Mirghomizadeh F, Pfister M, Apaydin F, Petit C, Kupka S, Pusch CM, et al. (July 2002). "Substitutions in the conserved C2C domain of otoferlin cause DFNB9, a form of nonsyndromic autosomal recessive deafness". Neurobiology of Disease. 10 (2): 157–164. doi:10.1006/nbdi.2002.0488. PMID 12127154. S2CID 37646982.
- Mirghomizadeh F, Pfister M, Blin N, Pusch CM (January 2003). "Uncommon cytidine-homopolymer dimorphism in 5'-UTR of the human otoferlin gene". International Journal of Molecular Medicine. 11 (1): 63–64. doi:10.3892/ijmm.11.1.63. PMID 12469219.
- Varga R, Kelley PM, Keats BJ, Starr A, Leal SM, Cohn E, et al. (January 2003). "Non-syndromic recessive auditory neuropathy is the result of mutations in the otoferlin (OTOF) gene". Journal of Medical Genetics. 40 (1): 45–50. doi:10.1136/jmg.40.1.45. PMC 1735255. PMID 12525542.
- Piechotta K, Garbarini N, England R, Delpire E (December 2003). "Characterization of the interaction of the stress kinase SPAK with the Na+-K+-2Cl- cotransporter in the nervous system: evidence for a scaffolding role of the kinase". The Journal of Biological Chemistry. 278 (52): 52848–52856. doi:10.1074/jbc.M309436200. PMID 14563843.
- Varga R, Avenarius MR, Kelley PM, Keats BJ, Berlin CI, Hood LJ, et al. (July 2006). "OTOF mutations revealed by genetic analysis of hearing loss families including a potential temperature sensitive auditory neuropathy allele". Journal of Medical Genetics. 43 (7): 576–581. doi:10.1136/jmg.2005.038612. PMC 2593030. PMID 16371502.
- Roux I, Safieddine S, Nouvian R, Grati M, Simmler MC, Bahloul A, et al. (October 2006). "Otoferlin, defective in a human deafness form, is essential for exocytosis at the auditory ribbon synapse". Cell. 127 (2): 277–289. doi:10.1016/j.cell.2006.08.040. PMID 17055430. S2CID 15233556.
 | This article on a gene on human chromosome 2 is a stub. You can help Wikipedia by adding missing information. |